Session Type
Meeting
Search Results for Pembrolizumab
Abstract Number: 745
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Case Presentation: Case1: A 72- year old male with a diagnosis of stage four non-small cell Lung carcinoma who was treated with Pembrolizumab, presented two weeks after his first dose with generalized body aches and weakness. Labs showed elevated creatinine Kinase, increased serum creatinine with hyperkalemia to 5.6 and elevated troponins to as high as […]
Abstract Number: 771
SHM Converge 2024
Case Presentation: A 69yo man was seen in preop clinic before cystoprostatectomy for a very large bladder tumor that had excellent radiographic response to pembrolizumab. His recent history was notable for an episode of witnessed syncope 5 weeks prior attributed to dehydration in the setting of baseline, long-standing intermittent episodes of SVT. Outpatient ECHO and […]
Abstract Number: 792
SHM Converge 2024
Case Presentation: A 56-year-old female with stage IIB T2N0M0, grade 3, and triple negative breast cancer, was treated with lumpectomy and neoadjuvant chemoimmunotherapy (dose-dense doxorubicin and cyclophosphamide followed by carboplatin/paclitaxel/pembrolizumab). This resulted in near-complete remission. However, evidence of residual disease was found and she was started on pembrolizumab and capecitabine for 3 months. She presented […]
Abstract Number: 797
SHM Converge 2023
Case Presentation: We present a 31-year-old female patient with a medical history significant for Stage II Breast cancer on Chemo and Immunotherapy (Pembrolizumab) who presents to the Emergency Department for the evaluation of nausea, vomiting, and generalized abdominal pain for 1 day. On arrival, the vital signs were within normal limits. On physical examination, generalized […]
Abstract Number: 889
SHM Converge 2024
Case Presentation: A 55-year-old female with a history of renal cell carcinoma treated with left-nephrectomy and Pembrolizumab-immunotherapy presents with complaints of weakness, orthostatic hypotension, nausea, and vomiting with food aversion. She had been admitted with similar complaints 9 times since her left nephrectomy, each time having received full workups including extensive sub-specialty evaluations including cardiology, […]
Abstract Number: C37
SHM Converge 2022
Case Presentation: A 78-year-old gentleman with a past medical history of scalp melanoma, renal papillary cell carcinoma, Ewing sarcoma, and end-stage renal disease presented to an outpatient Oncology appointment with bilateral ptosis, diplopia, myalgias, and bilateral proximal leg weakness less than one week following pembrolizumab infusion and influenza vaccination. He was sent to outpatient Neurology […]
Abstract Number: E32
SHM Converge 2022
Case Presentation: A 67-year-old woman with a history of metastatic squamous cell carcinoma of the lungs and plaque psoriasis presented with subacute pruritic and painful descaling lesions of the skin after pembrolizumab maintenance therapy (Figure 1.A). The lesions on the skin were erythematous and desquamating, worse in the upper extremities, lower extremities, abdomen, and trunk. […]
Abstract Number: L46
SHM Converge 2022
Case Presentation: Immune checkpoint inhibitors have evolved into the conventional therapy regimen for many cancer types. The major categories of immune checkpoint inhibitors include monoclonal antibodies against cytotoxic T lymphocyte antigen (CTLA-4), programmed cell death protein-1 (PD-1) and programmed cell death ligand molecules (PD-L1). Pembrolizumab has been implicated in causing hepatitis Discussion: An 89-year-old Caucasian […]
Abstract Number: M33
SHM Converge 2022
Case Presentation: A 71 year old male with a history of COPD, Hypothyroidism and Stage IIIA Lung Cancer status post wedge resection and prior treatment with chemotherapy and radiation currently on Pembrolizumab who presented with a two week history of fatigue. He denied any recent steroid use. Physical exam revealed hypotension and blood pressures dropping […]
Abstract Number: 1117
Hospital Medicine 2020, Virtual Competition
Case Presentation: An 84 year-old female with metastatic bladder cancer was admitted for a one month history of progressively worsening fatigue, bilateral ptosis, dysphagia, dyspnea, and lower extremity weakness. She was previously diagnosed with localized urothelial carcinoma in 2005 with recurrence in 2017 with pelvic metastases seen on surveillance imaging. She underwent chemotherapy, cystectomy, and […]